Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSA-screening for prostate cancer--yes or no?].

F Recker1, M Kwiatkowski

  • 1Urologische Klinik, Kantonsspital Aarau. franz.recker@ksa.ch

Therapeutische Umschau. Revue Therapeutique
|July 16, 2004
PubMed
Summary

Prostate cancer screening decisions require informed consent. While early detection can cure localized disease, mass screening

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.

Breast (Edinburgh, Scotland)·2026
Same author

Contemporary perspectives and debates in student ultrasound education: exploring didactic elements and theoretical aspects.

BMC medical education·2026
Same author

Breast assessment using next generation handheld ultrasound device based on silicon chips: a pilot study in senology.

Archives of gynecology and obstetrics·2026
Same author

Assessment of Cyclic Alternating Pattern of sleep during late pregnancy.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Design and implementation of a microlearning-based OSCE preparatory curriculum in obstetrics: a pilot study.

Archives of gynecology and obstetrics·2025
Same author

Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Area of Science:

  • Urology
  • Oncology
  • Public Health

Context:

  • Prostate cancer is a leading cause of cancer death in industrialized nations.
  • Demographic shifts are expected to increase its future importance.
  • Current evidence on mass screening effectiveness for reducing mortality is inconclusive.

Purpose:

  • To evaluate the uncertainties surrounding mass prostate cancer screening.
  • To inform healthcare providers and patients about the benefits and harms of early detection.
  • To guide decision-making regarding prostate cancer screening protocols.

Summary:

  • Early detection and localized treatment offer a cure for organ-confined prostate cancer.
  • Mass screening's definitive value in reducing prostate cancer mortality requires further proof from randomized controlled studies.
  • Medical societies recommend informed patient decisions on screening, considering risks, diagnostics, and treatment consequences.

Impact:

  • Informed decision-making for prostate cancer screening can improve patient outcomes.
  • Further research, including ERSPC and PLCO trials, is crucial for understanding mass screening benefits and harms.
  • Clarifying the role of PSA levels and free/total PSA ratio in biopsy decisions is essential.

Related Experiment Videos